CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BioBlocks focuses on drug discovery, aiming to expedite the development of new medications. Their Leap-to-Lead™ concept combines a fragment library with a vast compound database to enhance the identification of potential drug candidates.
Health and wellbeing are among the basic and most important needs of humanity.
Medicines have a major impact on the quality of life and are essential for treating various diseases.
Despite the numerous achievements of the pharmaceutical industry, there are still diseases without effective treatment.
Pharmaceutical industry is continuously searching for new compounds that can become drug candidates against such diseases.
Development of one new drug can take about 15 years, cost up to 2-5 billion…
BIOBLOCKS MAGYARORSZAG GYOGYSZERKEMIAI ES FEJLESZTO KFT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
